Form 8-K - Current report:
SEC Accession No. 0001193125-22-209391
Filing Date
2022-08-02
Accepted
2022-08-02 07:40:56
Documents
12
Period of Report
2022-08-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d384999d8k.htm   iXBRL 8-K 24601
  Complete submission text file 0001193125-22-209391.txt   149929

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rphm-20220802.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rphm-20220802_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rphm-20220802_pre.xml EX-101.PRE 11708
6 EXTRACTED XBRL INSTANCE DOCUMENT d384999d8k_htm.xml XML 3474
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 221126904
SIC: 2834 Pharmaceutical Preparations